Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2026-02-24 @ 4:46 AM
Study NCT ID:
NCT01579318
Status:
TERMINATED
Last Update Posted:
2023-05-15
First Post:
2012-04-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma
Sponsor:
OncoSec Medical Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2014-06-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-15
First Submit QC Date:
None
Study First Post Date:
2012-04-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-27
Results First Submit QC Date:
None
Results First Post Date:
2018-01-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-11
Last Update Post Date:
2023-05-15
Last Update Post Date Type:
ACTUAL